Our Perspectives
THREAD Blog
AI-Driven Automation: Understanding Its Power to Transform Clinical Research
There are so many announcements made every day about different corporate collaborations, that it may not immediately be clear what it means that THREAD will be working with AWS. For those involved in conducting clinical trials, it means a significant step forward in efficiency and data quality.
Value of DCT Approaches in Rare Disease Trials
Clinical trials for rare disease therapies pose unique challenges. Rare disease studies tend to be complex, due to a lack of historical data, well-defined clinical endpoints and available comparators. Rare conditions, inherently, mean that the pool of potential study candidates will be small which causes challenges to recruitment, as does the fact that these participants are often managing debilitating conditions. All of this increases pressure on the study team to keep enrolled participants engaged and to try to prevent dropouts.
What we've learned after conducting 100 DCTs
How do you, in a measured way, conduct and scale a decentralized trial? We may not have decentralized trials entirely figured out as we are still learning, adapting, and trying to optimize the decentralized clinical trial approach to be a better experience for everyone involved, however, we can share what we have learned after conducting 100 decentralized studies with THREAD.